Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma.
Merkx RIJ, Lobeek D, Konijnenberg M, Jiménez-Franco LD, Kluge A, Oosterwijk E, Mulders PFA, Rijpkema M. Merkx RIJ, et al. Among authors: oosterwijk e. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3277-3285. doi: 10.1007/s00259-021-05271-w. Epub 2021 Mar 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 33651116 Free PMC article. Clinical Trial.
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF. Oosterwijk-Wakka JC, et al. Among authors: oosterwijk e. J Immunother. 2002 Nov-Dec;25(6):500-8. doi: 10.1097/00002371-200211000-00006. J Immunother. 2002. PMID: 12439347 Clinical Trial.
Correspondence re: Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, D. Carey, and D. T. Curiel, Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002.
Jongmans W, Tiemessen DM, Oosterwijk E, Mulders PF. Jongmans W, et al. Among authors: oosterwijk e. Cancer Res. 2003 Apr 15;63(8):1994-5. Cancer Res. 2003. PMID: 12702594 No abstract available.
Immunotherapy for renal cell carcinoma.
Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: oosterwijk e. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.
Targeting of adenovirus to human renal cell carcinoma cells.
Jongmans W, van den Oudenalder K, Tiemessen DM, Molkenboer J, Willemsen R, Mulders PF, Oosterwijk E. Jongmans W, et al. Among authors: oosterwijk e. Urology. 2003 Sep;62(3):559-65. doi: 10.1016/s0090-4295(03)00378-9. Urology. 2003. PMID: 12946777
Tumor antigens and markers in renal cell carcinoma.
Mulders P, Bleumer I, Oosterwijk E. Mulders P, et al. Among authors: oosterwijk e. Urol Clin North Am. 2003 Aug;30(3):455-65. doi: 10.1016/s0094-0143(03)00024-7. Urol Clin North Am. 2003. PMID: 12953748 Review.
264 results